Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Peritonitis D010538 38 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Spasm D013035 5 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Thalassemia D013789 8 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zhou W et al. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. 1992 J. Immunol. pmid:1506691
Cooper K et al. 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives. 1992 J. Med. Chem. pmid:1507200
Moritoki H et al. Possible involvement of NO pathway in PAF-induced vasorelaxation. 1992 Jpn. J. Pharmacol. pmid:1507620
Xu Y and Tao YX Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. 2004 Neuroreport pmid:15076749
Slomiany BL and Slomiany A Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation. 2004 J. Physiol. Pharmacol. pmid:15082869
Steel HC and Anderson R Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils. 2004 Clin. Exp. Immunol. pmid:15086388
Reeves SR and Gozal D Platelet-activating factor receptor modulates respiratory adaptation to long-term intermittent hypoxia in mice. 2004 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15087283
Hollmann MW et al. Time-dependent inhibition of G protein-coupled receptor signaling by local anesthetics. 2004 Anesthesiology pmid:15087620
Bate C et al. The role of platelet activating factor in prion and amyloid-beta neurotoxicity. 2004 Neuroreport pmid:15094513
Northover AM In vitro effects of PAF on venous endothelial cell actin disposition. 1992 Agents Actions pmid:1509977
Yang YM et al. Creation of reversed phase high-performance liquid chromatographic technique to assay platelet-activating factor. 2004 J. Zhejiang Univ. Sci. pmid:15101112
Brown GE et al. Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase. 2004 J. Biol. Chem. pmid:15102856
Wheelan P and Clay KL Albumin and fatty acid effects on the stimulated production of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) by human polymorphonuclear leukocytes. 1992 Biochim. Biophys. Acta pmid:1511005
Khreiss T et al. Activation of extracellular signal-regulated kinase couples platelet-activating factor-induced adhesion and delayed apoptosis of human neutrophils. 2004 Cell. Signal. pmid:15115659
Ninio E et al. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. 2004 Hum. Mol. Genet. pmid:15115767
Schreiber S et al. The role of the mucosal immune system in inflammatory bowel disease. 1992 Gastroenterol. Clin. North Am. pmid:1512051
Hirafuji M and Shinoda H Antagonism of platelet-activating factor-induced increase in cytosolic free calcium concentration in human endothelial cells. 1992 Jpn. J. Pharmacol. pmid:1513073
Poli G et al. Oxidative stress and cell signalling. 2004 Curr. Med. Chem. pmid:15134513
Yang Y et al. Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis. 2004 Gut pmid:15138217
Burgos RA et al. Determination of specific receptor sites for platelet activating factor in bovine neutrophils. 2004 Am. J. Vet. Res. pmid:15141884
Wang J et al. [Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome]. 2004 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:15143716
Schauer U et al. Enhanced production of platelet activating factor by peripheral granulocytes from children with asthma. 1992 Allergy pmid:1514664
Ekholm J et al. The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor. 1992 Anal. Biochem. pmid:1514698
Fu H et al. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8. 2004 Immunology pmid:15147563
Beaudeux JL et al. Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression. 2004 Clin. Chim. Acta pmid:15149885
Lee SH et al. Role of messenger RNA expression of platelet activating factor and its receptor in porcine in vitro-fertilized and cloned embryo development. 2004 Biol. Reprod. pmid:15151927
Ishii S et al. Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model. 2004 J. Immunol. pmid:15153532
Tokiwano T et al. Biosynthesis of phomactins: common intermediate phomactatriene and taxadiene. 2004 Chem. Commun. (Camb.) pmid:15154058
Zhang C et al. The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats. 2004 Am. J. Chin. Med. pmid:15154282
Saint-Martin F et al. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. 2004 J Investig Allergol Clin Immunol pmid:15160440
Stephens CJ et al. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery. 1992 Cardiovasc. Res. pmid:1516109
Weinberg JR Fever, cytokines and shock. 1992 Cent Afr J Med pmid:1516118
Ruiz J et al. Effects of inhaled platelet activating factor on bronchial responsiveness in patients with symptomatic and asymptomatic pulmonary embolism. 1992 Chest pmid:1516409
Hla T Prostaglandins & other lipid mediators: a new phase, a new team. 2004 Prostaglandins Other Lipid Mediat. pmid:15165026
Ruan Z et al. Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. 2004 Prostaglandins Other Lipid Mediat. pmid:15165033
Nomikos TN et al. Application of a TCA-precipitation method for the determination of 1-alkyl-sn-glycero-3-phosphate: Acetyl-CoA acetyltransferase in human renal tissue. 2004 Prostaglandins Other Lipid Mediat. pmid:15165037
Kato M et al. Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. 2004 Int. Arch. Allergy Immunol. pmid:15166482
Pédrono F et al. Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15172680
Watanabe M et al. Preparation of immunoaffinity mini-columns for the analysis of platelet activating factor (PAF) in biological samples. 1992 J. Chromatogr. pmid:1517334
Zimmerman GA and McIntyre TM PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. 2004 Trends Mol Med pmid:15177186
Leong LL et al. The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog. 1992 J. Mol. Cell. Cardiol. pmid:1518080
Besana A et al. Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. 2004 J. Biol. Chem. pmid:15184378
Michail S and Abernathy F A new model for studying eosinophil migration across cultured intestinal epithelial monolayers. 2004 J. Pediatr. Gastroenterol. Nutr. pmid:15187782
Lu H and Xue XD [Platelet-activating factor and neonatal necrotizing enterocolitis]. 2004 Zhonghua Er Ke Za Zhi pmid:15189692
Seyffarth G et al. Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture. 2004 Reprod. Biol. Endocrinol. pmid:15191613
Tsironis LD et al. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. 2004 Cardiovasc. Res. pmid:15194469
Warren JS Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. 1992 Am. J. Pathol. pmid:1519663
Arima M et al. [Platelet activating factor (PAF)-induced late asthmatic response in sensitized but not in non-sensitized guinea pigs]. 1992 Arerugi pmid:1520069
Bate C et al. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. 2004 J. Biol. Chem. pmid:15210691
Jakubowski A et al. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. 2004 J. Physiol. Pharmacol. pmid:15213362
Tranquille N and Emeis JJ The involvement of products of the phospholipase pathway in the acute release of tissue-type plasminogen activator from perfused rat hindlegs. 1992 Eur. J. Pharmacol. pmid:1521562
Ma YQ et al. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. 2004 Blood pmid:15217824
Du YM et al. Effects of platelet activating factor on action potentials and potassium channels in guinea-pig ventricular myocytes. 2004 Sheng Li Xue Bao pmid:15224138
Wang C and Tai HH A sensitive and specific radioimmunoassay for platelet-activating factor. 1992 Lipids pmid:1522765
Vrzheshch PV et al. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets. 1992 Thromb. Res. pmid:1523610
Teng CM et al. Antiplatelet actions of some coumarin compounds isolated from plant sources. 1992 Thromb. Res. pmid:1523611
Roudebush WE et al. Platelet-activating factor significantly enhances intrauterine insemination pregnancy rates in non-male factor infertility. 2004 Fertil. Steril. pmid:15236989
Zhelev DV et al. Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants. 2004 Biophys. J. pmid:15240502
Shio MT et al. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells. 2004 Exp. Cell Res. pmid:15242784
Al-Darmaki S et al. Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response. 2004 Clin. Diagn. Lab. Immunol. pmid:15242947
PAF symposium on allergic, respiratory and cardiovascular diseases, Tokyo, 13-15 February 1991. Selected papers--symposium proceedings. 1992 Jun-Jul J Lipid Mediat pmid:1525348
Bussolino F et al. Protein kinase C activation in murine endothelioma cell lines containing middle T antigen stimulated by platelet-activating factor. 1992 Jun-Jul J Lipid Mediat pmid:1525349
Oh-ishi S et al. Production of platelet-activating factor in inflammatory exudate. 1992 Jun-Jul J Lipid Mediat pmid:1525350
Yukawa T et al. Sensitization primes platelet-activating factor (PAF)-induced accumulation of eosinophils in mouse skin lesions: contribution of cytokines to the response. 1992 Jun-Jul J Lipid Mediat pmid:1525351
Tokumura A et al. Formation of PAF-like compounds by peroxidation of phospholipids from bovine brain. 1992 Jun-Jul J Lipid Mediat pmid:1525352
Uda H et al. PAF-induced production of M-CSF in guinea-pig bone marrow. 1992 Jun-Jul J Lipid Mediat pmid:1525353
Saito H et al. PAF-induced eosinophilic and basophilic differentiation in human hematopoietic precursor cells. 1992 Jun-Jul J Lipid Mediat pmid:1525354
Fukuda T et al. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils. 1992 Jun-Jul J Lipid Mediat pmid:1525356
Barnes PJ PAF, eosinophils and asthma. 1992 Jun-Jul J Lipid Mediat pmid:1525357
Lefort J et al. Is platelet-activating factor involved in bronchopulmonary hyperresponsiveness? 1992 Jun-Jul J Lipid Mediat pmid:1525358
Minoguchi K et al. The mechanism of airway hyperresponsiveness following immediate asthmatic response in ovalbumin-sensitized guinea-pigs. 1992 Jun-Jul J Lipid Mediat pmid:1525359
Inoue H et al. Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs. 1992 Jun-Jul J Lipid Mediat pmid:1525360
Ohno S et al. The roles of platelet-activating factor (PAF) in pulmonary vasoconstriction during venous air embolism in anesthetized mongrel dogs. 1992 Jun-Jul J Lipid Mediat pmid:1525361
Furukawa M et al. PAF in human respiratory diseases. 1992 Jun-Jul J Lipid Mediat pmid:1525362
Nakamura T et al. Platelet-activating factor in Japanese cedar pollinosis. 1992 Jun-Jul J Lipid Mediat pmid:1525363
Lai CK et al. Should PAF inhalation challenge be used as an experimental model of bronchial hyperresponsiveness in man? 1992 Jun-Jul J Lipid Mediat pmid:1525364
Seo KH et al. Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. 2004 Eur. J. Immunol. pmid:15259010
Ebiike H et al. Lipase-catalyzed enantioselective hydrolysis of 4-alkyl-1,4-dihydropyridine derivatives: synthesis of (+)- and (-)-methyl 2-(phenylthio)ethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate (PCA 4248). 1992 Chem. Pharm. Bull. pmid:1525941
Misso NL and Thompson PJ Xanthines inhibit human platelet aggregation induced by platelet-activating factor. 1992 Clin. Exp. Pharmacol. Physiol. pmid:1526066
Mita M and Ueta N Fatty chains of alkenylacyl, alkylacyl and diacyl phospholipids in sea urchin spermatozoa. 1992 Comp. Biochem. Physiol., B pmid:1526122
Zhu P et al. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. 2004 J. Neurosci. Res. pmid:15264222
Sarchielli P et al. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. 2004 Cephalalgia pmid:15265050
Frenkel RA and Johnston JM Metabolic conversion of platelet-activating factor into ethanolamine plasmalogen in an amnion-derived cell line. 1992 J. Biol. Chem. pmid:1527040
Chami O et al. Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15271646
Fourcade O et al. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. 2004 Anesth. Analg. pmid:15271713
Rasheed H and Saeed SA Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation. 2004 Exp. Mol. Med. pmid:15272233
Sumita C et al. Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophage. 2004 Biochim. Biophys. Acta pmid:15279882
Corcoran PC et al. Platelet activating factor antagonist enhances lung preservation. 1992 J. Surg. Res. pmid:1528038
Llodrá J et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15280540
Kato M et al. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. 2004 J. Pharmacol. Sci. pmid:15286429
Zinchuk O et al. Dynamics of PAF-induced conjunctivitis reveals differential expression of PAF receptor by macrophages and eosinophils in the rat. 2004 Cell Tissue Res. pmid:15290234
Dulioust A et al. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. 1992 Scand. J. Rheumatol. pmid:1529281
Xu Y et al. Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons. 2004 Exp. Neurol. pmid:15296832
Wanten G et al. Lipid effects on neutrophil calcium signaling induced by opsonized particles: platelet activating factor is only part of the story. 2004 Clin Nutr pmid:15297099
Tabor BL et al. Platelet-activating factor antagonists decrease lung protein leak in preterm ventilated rabbits. 1992 Am. J. Obstet. Gynecol. pmid:1530043
Berdeli A et al. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15301793
Triggiani M et al. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 1992 Biochem. J. pmid:1530582
Ma X et al. [Corneal epithelial wound healing is delayed by platelet activating factor treatment]. 2004 Zhonghua Yan Ke Za Zhi pmid:15307983
Venkatesha RT et al. Platelet-activating factor-induced chemokine gene expression requires NF-kappaB activation and Ca2+/calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment. 2004 J. Biol. Chem. pmid:15308653
Buke AC et al. Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. 2004 Sep-Oct Med Princ Pract pmid:15316260